本網站中所有資料(包括圖檔及文字檔),著作權皆屬本會所有(除另有註明者,或本會網站連結至外部之網站除外),如有引用,請確實註明出處來源。<完整資訊>
© 2024 Institute for Biotechnology and Medicine Industry (IBMI) All rights reserved.
地址:115 台北市南港區忠孝東路七段508號9樓
電話:(02)2655-8168
傳真:(02)2655-7978
排名 | 類別 | 公司 | 2023年總營收(億) | 2022年總營收(億) | 年成長率(%) | 3年年複合成長率(%) | 排名變化 |
---|---|---|---|---|---|---|---|
1 | 上市 | 美時(1795) | 169.6 | 146.3 | 15.9 | 10.4 | +1 |
2 | 上櫃 | 大樹(6469) | 161.3 | 145.8 | 10.6 | 12.7 | +1 |
3 | 上市 | 保瑞(6472) | 142.0 | 103.2 | 35.3 | 42.5 | +2 |
4 | 上市 | 葡萄王(1707) | 106.4 | 103.9 | 2.4 | 2.8 | +0 |
5 | 上市 | 中化(1701) | 85.7 | 82.6 | 1.4 | 2.4 | +2 |
6 | 上市 | 佳醫(4104) | 82.3 | 71.9 | 14.6 | 7.8 | +5 |
7 | 上櫃 | 大江(8436) | 80.2 | 74.3 | 7.8 | -2.2 | +1 |
8 | 上櫃 | 杏一(4175) | 74.5 | 72.3 | 3.0 | 4.4 | +2 |
9 | 上市 | 永信(3705) | 70.3 | 73.1 | -3.9 | -3.4 | +0 |
10 | 上市 | 晶碩(6491) | 67.9 | 63.2 | 7.4 | 6.6 | +3 |
11 | 上市 | 生達(1720) | 62.4 | 58.5 | 6.7 | 10.7 | +3 |
12 | 上櫃 | 東洋(4105) | 54.8 | 50.6 | 8.3 | 6.5 | +4 |
13 | 上櫃 | 健喬(4114) | 51.2 | 44.0 | 16.5 | 16.5 | +7 |
14 | 上櫃 | 藥華藥(6446) | 51.1 | 28.8 | 77.2 | 97.8 | +21 |
15 | 上櫃 | 合富-KY(4745) | 48.4 | 56.2 | -13.9 | -2.0 | +0 |
16 | 上市 | 泰博(4736) | 48.1 | 96.3 | -50.1 | -9.5 | -10 |
17 | 上櫃 | 友華(4120) | 45.8 | 47.3 | -3.2 | -1.3 | +1 |
18 | 上櫃 | 明基醫(4116) | 45.4 | 43.8 | 3.8 | 46.0 | +1 |
19 | 上市 | 麗豐-KY(4137) | 45.3 | 40.7 | 11.4 | -4.9 | +5 |
20 | 上櫃 | 精華(1565) | 43.9 | 50.0 | -12.2 | -6.7 | -3 |
排名 | 公司名稱 (代號) |
營收-億元(同期成長率) | ||||
---|---|---|---|---|---|---|
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2023Q1-Q4 | ||
1 | 美時(1795) | 45.2(43.0%) | 44.5(52.9%) | 45.7(-15.2%) | 34.2(7.9%) | 169.6(15.9%) |
2 | 保瑞(6472) | 48.6(333.9%) | 30.6(126.7%) | 30.7(12.5%) | 32.1(-39.3%) | 142.0(35.4%) |
3 | 葡萄王(1707) | 22.2(8.3%) | 26.6(-2.6%) | 25.6(2.8%) | 32.0(2.6%) | 106.4(2.4%) |
4 | 中化(1701) | 21.1(8.2%) | 21.2(1.4%) | 21.2(2.9%) | 22.2(-5.9%) | 85.7(1.3%) |
5 | 佳醫(4104) | 20.2(18.1%) | 20.1(20.4%) | 20.2(9.8%) | 21.8(10.7%) | 82.3(14.5%) |
6 | 永信(3705) | 16.7(-14.4%) | 17.0(-13.3%) | 17.4(7.4%) | 19.2(7.9%) | 70.3(-3.8%) |
7 | 晶碩(6491) | 14.6(-2.0%) | 16.1(14.2%) | 16.8(2.4%) | 20.4(14.6%) | 67.9(7.4%) |
8 | 生達(1720) | 14.9(20.2%) | 15.1(2.0%) | 16.5(6.5%) | 15.9(0.6%) | 62.4(6.7%) |
9 | 泰博(4736) | 15.4(-14.0%) | 11.9(-67.2%) | 10.0(-58.3%) | 10.8(-40.3%) | 48.1(-50.1%) |
10 | 麗豐-KY(4137) | 9.5(-7.8%) | 11.2(45.5%) | 12.4(2.5%) | 12.2(15.1%) | 45.3(11.3%) |
11 | 台耀(4746) | 9.3(12.0%) | 10.9(29.8%) | 11.3(9.7%) | 12.1(13.1%) | 43.6(15.6%) |
12 | 承業醫(4164) | 8.0(31.1%) | 8.9(29.0%) | 7.3(-11.0%) | 14.6(71.8%) | 38.8(30.6%) |
13 | 神隆(1789) | 6.5(-12.2%) | 7.5(-6.2%) | 6.6(-7.0%) | 11.3(11.9%) | 31.9(-2.1%) |
14 | 佐登-KY(4190) | 7.8(21.9%) | 8.2(26.2%) | 6.7(0.0%) | 7.1(-14.5%) | 29.8(6.8%) |
15 | 杏輝(1734) | 7.7(14.9%) | 7.3(2.8%) | 7.2(1.4%) | 7.4(-3.9%) | 29.6(3.5%) |
16 | 全宇生技-KY(4148) | 7.8(16.4%) | 8.0(-13.0%) | 6.8(-45.2%) | 5.6(-36.4%) | 28.2(-24.0%) |
17 | 雃博(4106) | 7.0(16.7%) | 7.0(2.9%) | 5.7(-17.4%) | 6.8(-1.4%) | 26.5(-0.4%) |
18 | 視陽(6782) | 5.2(-20.0%) | 5.4(-26.0%) | 6.5(-8.5%) | 6.8(-1.4%) | 23.9(-14.0%) |
19 | 南光(1752) | 5.7(50.0%) | 5.3(12.8%) | 5.3(8.2%) | 5.2(-13.3%) | 21.5(10.8%) |
20 | 中化生(1762) | 7.7(45.3%) | 5.2(-10.3%) | 3.4(-26.1%) | 4.6(-16.4%) | 20.9(-1.4%) |
排名 | 公司名稱 (代號) |
營收-億元(同期成長率) | ||||
---|---|---|---|---|---|---|
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2023Q1-Q4 | ||
1 | 大樹(6469) | 38.2(19.4%) | 40.6(2.3%) | 40.5(11.9%) | 42.0(10.8%) | 161.3(10.6%) |
2 | 大江(8436) | 18.7(12.7%) | 19.7(6.5%) | 22.1(7.3%) | 19.7(5.9%) | 80.2(7.9%) |
3 | 杏一(4175) | 17.5(8.7%) | 18.4(-9.8%) | 18.6(8.8%) | 20.0(7.0%) | 74.5(3.0%) |
4 | 東洋(4105) | 11.7(12.5%) | 12.6(8.6%) | 14.3(7.5%) | 16.2(5.9%) | 54.8(8.3%) |
5 | 健喬(4114) | 12.5(28.9%) | 13.1(23.6%) | 12.3(11.8%) | 13.3(4.7%) | 51.2(16.4%) |
6 | 藥華藥(6446) | 8.9(256.0%) | 12.6(28.6%) | 13.1(61.7%) | 16.5(96.4%) | 51.1(77.4%) |
7 | 合富-KY(4745) | 11.8(-13.2%) | 13.1(-5.8%) | 11.8(-20.3%) | 11.7(-15.8%) | 48.4(-13.9%) |
8 | 友華(4120) | 11.5(0.9%) | 11.3(-6.6%) | 11.0(0.0%) | 12.0(-6.2%) | 45.8(-3.2%) |
9 | 明基醫(4116) | 6.9(11.3%) | 7.3(-8.8%) | 19.1(7.3%) | 12.1(2.5%) | 45.4(3.7%) |
10 | 精華(1565) | 11.3(-16.3%) | 10.8(-11.5%) | 10.5(-18.6%) | 11.3(-0.9%) | 43.9(-12.2%) |
11 | 大學光(3218) | 10.3(22.6%) | 10.0(28.2%) | 10.6(15.2%) | 9.9(4.2%) | 40.8(16.9%) |
12 | 聯合(4129) | 9.3(25.7%) | 9.3(22.4%) | 9.4(27.0%) | 11.3(21.5%) | 39.3(24.0%) |
13 | 寶島科(5312) | 9.8(19.5%) | 9.4(30.6%) | 9.9(11.2%) | 9.9(10.0%) | 39.0(17.1%) |
14 | 杏昌(1788) | 9.7(-1.0%) | 9.6(-45.5%) | 9.8(-1.0%) | 9.9(3.1%) | 39.0(-16.8%) |
15 | 盛弘(8403) | 9.0(-13.5%) | 9.3(-17.0%) | 9.7(-8.5%) | 10.7(16.3%) | 38.7(-6.5%) |
16 | 優盛(4121) | 9.3(2.2%) | 9.9(-23.8%) | 9.3(-13.1%) | 9.6(-9.4%) | 38.1(-12.2%) |
17 | 軒郁(6703) | 5.1(59.4%) | 6.5(58.5%) | 7.8(95.0%) | 10.3(77.6%) | 29.7(73.7%) |
18 | 茂生農經(1240) | 7.5(-1.3%) | 6.7(-23.9%) | 7.1(-13.4%) | 7.7(-15.4%) | 29.0(-13.9%) |
19 | 鐿鈦(4163) | 6.6(29.4%) | 6.1(7.0%) | 5.9(-11.9%) | 5.8(-12.1%) | 24.4(1.2%) |
20 | 太醫(4126) | 6.3(26.0%) | 5.9(22.9%) | 5.8(-1.7%) | 5.2(-14.8%) | 23.2(6.4%) |
排名 | 公司名稱 (代號) |
營收-億元(同期成長率) | ||||
---|---|---|---|---|---|---|
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2023Q1-Q4 | ||
1 | 諾貝兒(6844) | 9.4(-3.1%) | 9.2(-27.0%) | 8.8(-10.2%) | 8.6(-13.1%) | 36.0(-14.3%) |
2 | 佑全(6929) | 7.7(6.9%) | 7.7(-23.8%) | 7.7(0.0%) | 8.1(1.2%) | 31.2(-5.5%) |
3 | 望隼(4771) | 5.1(41.7%) | 5.5(34.1%) | 7.1(36.5%) | 8.1(50.0%) | 25.8(41.0%) |
4 | 麗彤(6539) | 4.2(-14.3%) | 3.9(-9.3%) | 3.5(-22.2%) | 3.8(-24.0%) | 15.4(-17.6%) |
5 | 康聯生醫(6665) | 3.3(-5.7%) | 2.9(-39.6%) | 3.2(-17.9%) | 3.2(-3.0%) | 12.6(-18.7%) |
6 | 永鴻生技(6936) | 3.1(-3.1%) | 2.8(-3.4%) | 3.2(14.3%) | 3.0(0.0%) | 12.1(1.7%) |
7 | 大武山(6952) | - | - | 3.2(3.2%) | 3.6(5.9%) | 11.5(-3.4%) |
8 | 漢達(6620) | 3.3(1000.0%) | 2.3(2200.0%) | 2.4(2300.0%) | 3.0(100.0%) | 11.0(450.0%) |
9 | 泰宗(4169) | 2.4(41.2%) | 2.3(15.0%) | 2.3(15.0%) | 2.7(17.4%) | 9.7(21.2%) |
10 | 瑩碩生技(6677) | 2.3(27.8%) | 2.2(15.8%) | 2.2(-8.3%) | 2.7(8.0%) | 9.4(9.3%) |
11 | 威力德生醫(7713) | - | - | - | - | 9.4(-9.6%) |
12 | 友霖(4166) | 2.0(66.7%) | 2.3(27.8%) | 2.0(53.8%) | 2.5(212.5%) | 8.8(72.5%) |
13 | 青松健康(6931) | 2.0(81.8%) | 2.1(40.0%) | 2.2(15.8%) | 2.4(26.3%) | 8.7(35.9%) |
14 | 優你康(4150) | 1.9(-13.6%) | 1.8(-10.0%) | 2.4(26.3%) | 2.4(9.1%) | 8.5(2.4%) |
15 | 康科特(6518) | 2.0(0.0%) | 2.0(-16.7%) | 2.1(-4.5%) | 2.2(-4.3%) | 8.3(-6.7%) |
16 | 善德生技(4115) | 2.0(-33.3%) | 1.6(-40.7%) | 2.0(-23.1%) | 2.1(-4.5%) | 7.7(-26.7%) |
17 | 安美得(7575) | 1.7(13.3%) | 1.8(12.5%) | 2.0(11.1%) | 2.1(5.0%) | 7.6(10.1%) |
18 | 普惠醫工(6543) | 1.6(0.0%) | 1.8(5.9%) | 2.1(23.5%) | 1.8(0.0%) | 7.3(7.4%) |
19 | 立弘(1780) | 2.0(25.0%) | 1.8(-10.0%) | 1.8(-10.0%) | 1.6(0.0%) | 7.2(0.0%) |
20 | 溫士頓(6817) | 1.5(15.4%) | 1.9(18.7%) | 1.8(20.0%) | 1.9(11.8%) | 7.1(16.4%) |
【相關文章】
2023 生醫上市櫃營收九大領域營收表現總覽